Oculis Holding AG (OCS) Shares Outstanding (Diluted) (2021 - 2026)

Oculis Holding AG (OCS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 138.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.24 Mn
Dec 31, 2025 52.24 Mn
Sep 30, 2025 52,288.91 Bn
Jun 30, 2025 52,288.91 Bn
Mar 31, 2025 40.41 Mn
Dec 31, 2024 40.41 Mn
Sep 30, 2024 2.03 Bn
Jun 30, 2024 2.03 Bn
Mar 31, 2024 29.90 Mn
Dec 31, 2023 29.90 Mn
Sep 30, 2023 33,565.54 Bn
Jun 30, 2023 33,565.54 Bn
Mar 31, 2023 2.99 Mn
Dec 31, 2022 2.99 Mn
Sep 30, 2022 2.78 Mn
Jun 30, 2022 2.78 Mn
Dec 31, 2021 2.78 Mn